Results from that study were also presented at the ADA meeting and published in The Lancet Diabetes and Endocrinology
Patients with BMI at or below 30 kg/m experienced a 15% relative risk reduction in major adverse cardiovascular events (HR 0.85
"Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species." E uropean Journal of Pharmaceutical Sciences 104(2017):31-41
Always check the regulations in your country before obtaining or using these peptides
Though the medication was originally developed as a diabetes drug, its been shown to be effective for a myriad of conditions, like polycystic ovarian syndrome and migraines
443 These agents exert their anti-atherosclerotic effects through various mechanisms, including by improving blood lipid profiles, 444 preserving endothelial integrity and regulating endothelial function, 445 as well as modulating inflammatory processes